Director/PDMR Shareholding (8653X)
December 13 2010 - 10:15AM
UK Regulatory
TIDMGWP
RNS Number : 8653X
GW Pharmaceuticals PLC
13 December 2010
GW Pharmaceuticals PLC
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the
"Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 13 December 2010: GW Pharmaceuticals (AIM:
GWP)hereby provides notification that the Company has today been
notified of the following share transactions entered into by Dr
Geoffrey Guy, a Director and Executive Chairman of the Company.
Dr Guy today exercised options over 150,000 ordinary shares of
0.1 pence each. These options were 10 year options which would have
expired if not exercised before 15 January 2011. Dr Guy
subsequently sold 200,000 ordinary shares at a price of 105.2 pence
per share. All options held by Dr Guy that were due to expire in
January 2011 have now been exercised.
Following these transactions, Dr Guy holds a beneficial interest
in 18 256,783 GW Pharmaceuticals 0.1 pence ordinary shares,
representing 13.89% of the Company's current issued share
capital.
The total number of shares outstanding in the Company is
131,393,292 ordinary shares of 0.1 pence each.
- Ends -
Enquiries:
GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900
James Steel/Vijay Barathan
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFLRFSLVLII
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles